Last Updated on December 31, 2023 by The Health Master
Mumbai: Lupin Limited announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA).
The company has received approval for Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial, to market as a generic equivalent of Perforomist Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty, L.P.
Formoterol Fumarate Inhalation Solution had an estimated annual sale of USD 282 million in the U.S.
USFDA gives nod for generic Carbamazepine tablets
USFDA gives approval for this BP monitor device
USFDA gives nod for generic Naproxen Sodium Softgel Capsules
USFDA gives approval for Rufinamide tablets
USFDA approves generic Vasopressin injection
USFDA gives approval for Meclizine HCL Tablets
NPPA fixes Retail Prices of 45 drug formulations
CDSCO panel wants justification on Protocol Amendments on Trail of Imlunestrant
USFDA gives nod for generic Carbamazepine tablets
FDA fixes upper limit for Wholesalers & Retailers for storage, sale of NDPS DRugs…
USFDA gives approval for this BP monitor device
Govt revises guidelines for PLI scheme domestic Medical Devices
UFDA issues Form 483 to Cipla’s facility in MP
Nicotine replacement therapy may become part of Essential Medicines List
Drug recall: Glenmark, Strides Pharma, Cipla recalled these drugs
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
